Myeloid Sarcoma immunostains

Myeloid Sarcoma immunostains
Author: Mir Alikhan, MD
Category: Myeloid Neoplasms and acute leukemia (WHO 2016) > Acute Myeloid Leukemia > Myeloid sarcoma
Published Date: 09/10/2021

Figure 3: The neoplastic cells were also positive for CD4 (A), CD56 (B), and CD163 (C). NPM1 immunostain (D) showed nuclear and cytoplasmic positivity, suggestive of an NPM1 mutation (image courtesy of Dr. Sandeep Gurbuxani, University of Chicago).  The cells were negative for MPO, CD123, TCL1, CD34, CD117, B-cell markers, and T-cells markers (not shown).